ClinicalTrials.gg
Sign In

Endocyte clinical trials

Acquired by Novartis, Dec 21, 2018 · source ↗

The registry lists 29 studies whose lead sponsor is Endocyte. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 30, 2026.

Before and after it joined Novartis

First submitted before Endocyte became part of Novartis
28
First submitted after Endocyte became part of Novartis
1
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Endocyte’s studies test, most studies first; none is open now — 8 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Endocyte’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 29 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting13%
  • Completed2276%
  • Stopped early621%Terminated 5 · Withdrawn 1

Phase

  • Phase 213
  • Phase 113
  • Phase 32

Where

  • United States18
  • Canada2
  • Belgium1
  • South Africa1
  • Netherlands1
  • Puerto Rico1

Over the years

  1. 407
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 10 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Endocyte29 studies

Something wrong with this grouping? Tell us on the Novartis page.

Studies

Recruiting first, then most recently updated. Showing 29 of 29. All Novartis studies →